Expense ratios are the best predictors of future success. They tend to be relatively stable, but they can move around more ...

Heading into the new year, these companies stand out from the competition and can be good choices for long-term investing.

Recently, the Chinese government has nudged its AI developers to shy away from Nvidia parts, so there’s no guarantee that the ...

Your plan will take care of you as you age. We're in our mid-70s and do not have children. Our estate will be large and very liquid, and we want to avoid arguments with disbursement of the estate ...

The USDA, during Trump's first term as president, launched a multibillion-dollar aid package, known as the Market Facilitation Program (MFP), to help U.S. farmers who were hurt by retaliatory tariffs ...

You should not give money because you feel pressured into it. Whether the sum is $500 or $5,000, be your authentic self and only give with a full heart. You should only give this money if you feel, ...

"Oracle is aggressively pursuing the inferencing market, as well as the AI-training market," Ellison said on the company's September earnings call with investors. "We think we are in a pretty good ...

The Magnum Ice Cream Company is entering its next phase as an independent business, with a refreshed management team and a more targeted strategic focus. Within Unilever, ice cream often ...

There are a number of issues that may weight on Berkshire Hathaway's stock after Buffett retires, but concerns over losing a key stock picker, Todd Combs, doesn't seem to be one of them.

Despite the volatility, equity markets have successfully negotiated various crises in 2025 and the S&P 500 SPX is on target for an annual return in the upper teens. That's not bad at all. But what ...

As Oracle emerges as the poster child for the AI bubble, the financial landscape beneath it is bending to accommodate a future of perpetually higher leverage. Credit-rating agencies and other ...

Pfizer is licensing a potential weight-loss drug from a unit of Shanghai Fosun Pharmaceutical in a collaboration potentially worth more than $2 billion for the Chinese healthcare company. Pfizer on ...